{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:21Z","timestamp":1790744121487,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/mcp.0000000000000307","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T14:14:01Z","timestamp":1467900841000},"page":"415-420","source":"Crossref","is-referenced-by-count":36,"title":["Interferon-induced pulmonary hypertension"],"prefix":"10.1097","volume":"22","author":[{"given":"Laurent","family":"Savale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Camille","family":"Chaumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20200527","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R2-5-20200527","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"key":"R3-5-20200527","first-page":"65","article-title":"Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapy","volume":"42","author":"Kramers","year":"1993","journal-title":"Neth J Med"},{"key":"R4-5-20200527","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s002770100298","article-title":"Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia","volume":"80","author":"Fruehauf","year":"2001","journal-title":"Ann Hematol"},{"key":"R5-5-20200527","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-7120-3-26","article-title":"Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report","volume":"3","author":"Jochmann","year":"2005","journal-title":"Cardiovasc Ultrasound"},{"key":"R6-5-20200527","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","article-title":"Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C","volume":"55","author":"Dhillon","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R7-5-20200527","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458509104593","article-title":"Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report","volume":"15","author":"Ledinek","year":"2009","journal-title":"Mult Scler"},{"key":"R8-5-20200527","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1183\/09031936.00057914","article-title":"Pulmonary arterial hypertension in patients treated with interferon","volume":"44","author":"Savale","year":"2014","journal-title":"Eur Respir J"},{"key":"R9-5-20200527","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000335064","article-title":"Sildenafil therapy for interferon-beta-1a-induced pulmonary arterial hypertension: a case report","volume":"120","author":"Caravita","year":"2011","journal-title":"Cardiology"},{"key":"R10-5-20200527","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.msard.2015.03.008","article-title":"Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?","volume":"4","author":"Govern","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"R11-5-20200527","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1155\/2015\/181535","article-title":"Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis","volume":"22","author":"Gibbons","year":"2015","journal-title":"Can Respir J"},{"key":"R12-5-20200527","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1183\/13993003.02327-2014","article-title":"Pulmonary arterial hypertension in patients treated with interferon","volume":"46","author":"Prella","year":"2015","journal-title":"Eur Respir J"},{"key":"R15-5-20200527","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/imj.12554","article-title":"Pulmonary arterial hypertension associated with the use of interferon therapy for chronic hepatitis C infection complicated by extrinsic left main coronary artery compression","volume":"44","author":"Anderson","year":"2014","journal-title":"Intern Med J"},{"key":"R16-5-20200527","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1183\/13993003.01376-2015","article-title":"Pulmonary arterial hypertension in patients treated with interferon","volume":"46","author":"Savale","year":"2015","journal-title":"Eur Respir J"},{"key":"R18-5-20200527","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","article-title":"Evidence for the involvement of type I interferon in pulmonary arterial hypertension","volume":"114","author":"George","year":"2014","journal-title":"Circ Res"},{"key":"R19-5-20200527","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary arterial hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"},{"key":"R20-5-20200527","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1183\/09031936.00188611","article-title":"Pulmonary hypertension associated with benfluorex exposure","volume":"40","author":"Savale","year":"2012","journal-title":"Eur Respir J"},{"key":"R21-5-20200527","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09059180.00003313","article-title":"Drug-induced pulmonary arterial hypertension: a recent outbreak","volume":"22","author":"Montani","year":"2013","journal-title":"Eur Respir Rev"},{"key":"R22-5-20200527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(99)00107-7","article-title":"Interferon-alpha elevates pulmonary blood pressure in sheep \u2013 the role of thromboxane cascade","volume":"370","author":"Hanaoka","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R23-5-20200527","doi-asserted-by":"crossref","first-page":"e46779","DOI":"10.1371\/journal.pone.0046779","article-title":"Effect of different interferonalpha 2 preparations on IP10 and ET-1 release from human lung cells","volume":"7","author":"Badiger","year":"2012","journal-title":"PLoS One"},{"key":"R24-5-20200527","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R25-5-20200527","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R26-5-20200527","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R27-5-20200527","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1073\/pnas.95.7.3851","article-title":"Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS","volume":"95","author":"Zagury","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-5-20200527","doi-asserted-by":"crossref","first-page":"e11110","DOI":"10.1371\/journal.pone.0011110","article-title":"Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients","volume":"5","author":"Lehmann","year":"2010","journal-title":"PLoS One"},{"key":"R29-5-20200527","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.1871","article-title":"Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections","volume":"14","author":"Mandl","year":"2008","journal-title":"Nat Med"},{"key":"R30-5-20200527","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1501481","article-title":"Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis","volume":"373","author":"Kappos","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCP.0000000000000307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:27:32Z","timestamp":1620944852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00063198-201609000-00005"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mcp.0000000000000307","relation":{},"ISSN":["1070-5287"],"issn-type":[{"value":"1070-5287","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}